I only have a few options for long term investment. Only choose those have a very good uptrend.
1. $SPDR S&P 500 ETF (SPY.US)$
This one never been go wrong. Just buy on the dip whenever you have money. Keep it for long term.
2. $Microsoft (MSFT.US)$
As you can see. This is one of most stable stocks with a very good uptrend.
Tips : Only buy on the dip and put trailing stop 1.5% for SPY because this is daily range for SPY.
As for MSFT that has daily range 2.4%, I will put trailing stop 2%.
You'll be surprised with the result when you're using this method.

$MARA Holdings (MARA.US)$ $MicroStrategy (MSTR.US)$
Seriously, the big pie bullish logic remains unchanged, but the mining stock valuation needs to be lowered because of interest rate hike expectations and market risk appetite changes. At present, choose to stay put, the second dip of the pie has not ended, such as the short-term rebound will sell part of the mining shares, divided into two, one can add leverage account to buy MSTR, the other take cash and so on the right side of the entry.

$Relmada Therapeutics (RLMD.US)$ $Denali Therapeutics (DNLI.US)$ $Tango Therapeutics (TNGX.US)$ $Goldman Sachs (GS.US)$ Goldman Sachs announced the latest list of potential acquisitions in the biopharmaceutical sector. Relmada, Denali and Tango have the most potential acquisition opportunities of the nine newly listed companies, Goldman sachs said. Relmada could trade at $115 a share, a 512% premium to its current price; Denali could trade at $166 a share, a 283% premium to its current price; Tango is likely to trade at $43.40 a share, a 295% premium to its current share price. The health care company with the biggest premium of the 24 companies listed is $uniQure NV (QURE.US)$, which Goldman estimates could trade at $174 a share, a 516% premium to its current price.